VRTX

NASDAQStock

Vertex Pharmaceuticals Incorporated

$479.41-13.10 (-2.66%)

52-Week Range

$366.54
$513.76

Key Stats

Market Cap

121.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.32

Volume

940.1K

Avg Volume

1.4M

Performance

1M

+3.66%

3M

+4.92%

6M

+21.60%

YTD

+5.75%

1Y

-4.93%

3Y

+61.94%

5Y

+117.68%

Price Chart

ETF Exposure

VRTX is held by 370 ETFs

ETFFund NameWeight
DMRLDeltaShares S&P 500 Managed Risk ETF0.14%
DFSUDimensional - US Sustainability Core 1 ETF0.14%
HIPRDirexion High Growth ETF0.14%
ACWIiShares MSCI ACWI ETF0.14%
UPROProShares - UltraPro S&P5000.14%
PRFInvesco RAFI US 1000 ETF0.13%
GLOVGoldman Sachs ActiveBeta World Low Vol Plus Equity ETF0.13%
GSWOGoldman Sachs ActiveBeta World Equity ETF0.13%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF0.13%
NZACState Street SPDR MSCI ACWI Climate Paris Aligned ETF0.13%
PHDGInvesco S&P 500 Downside Hedged ETF0.13%
JHMLJohn Hancock Investments - Multifactor Large Cap ETF0.12%
MXDUNationwide Maximum Diversification U.S. Core Equity ETF0.12%
CRBNiShares Low Carbon Optimized MSCI ACWI ETF0.11%
VTVanguard Total World Stock ETF0.11%
GSLCGoldman Sachs ActiveBeta U.S. Large Cap Equity ETF0.11%
SPUTInnovator Equity Premium Income – Daily PutWrite ETF0.11%
FNDXSchwab Fundamental U.S. Large Company Index ETF0.10%
AIEQAmplify AI Powered Equity ETF0.10%
SPUUDirexion Daily S&P 500 Bull 2X ETF0.10%
DFVXDimensional - US Large Cap Vector ETF0.10%
VLUState Street SPDR S&P 1500 Value Tilt ETF0.10%
EQALInvesco Russell 1000 Equal Weight ETF0.10%
DFLVDimensional - US Large Cap Value ETF0.10%
FNDBSchwab Fundamental U.S. Broad Market Index ETF0.09%
MMTMState Street SPDR S&P 1500 Momentum Tilt ETF0.09%
DFACDimensional - US Core Equity 2 ETF0.09%
IUSInvesco RAFI Strategic US ETF0.09%
LSLTPacer Salt Low truBeta US Market ETF0.09%
SLTPacer Salt High truBeta US Market ETF0.09%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.09%
VETSPacer Military Times Best Employers ETF0.09%
VIRSPacer BioThreat Strategy ETF0.09%
HCMTDirexion HCM Tactical Enhanced US ETF0.08%
QARPXtrackers Russell 1000 US Quality at a Reasonable Price ETF0.08%
GEWCambria Global EW ETF0.08%
VFVAVanguard U.S. Value Factor ETF0.07%
RVRSArrow Reverse Cap 500 ETF0.07%
RWLInvesco S&P 500 Revenue ETF0.07%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.07%
DCORDimensional - US Core Equity 1 ETF0.07%
CPIIQ Real Return ETF0.07%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.06%
ITDGiShares LifePath Target Date 2055 ETF0.06%
ITDHiShares LifePath Target Date 2060 ETF0.06%
ITDIiShares LifePath Target Date 2065 ETF0.06%
ITDJiShares LifePath Target Date 2070 ETF0.06%
ITDFiShares LifePath Target Date 2050 ETF0.05%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.05%
AOAiShares Core 80/20 Aggressive Allocation ETF0.05%
PreviousPage 7 of 8Next

About VRTX ETF Exposure

Vertex Pharmaceuticals Incorporated (VRTX) is held by 370 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.8B, VRTX is a widely held institutional stock. The stock currently trades at $479.41. Investors can gain exposure to VRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRTX, sorted by portfolio weight.